Back
|
Cell No. : Cell Name
HPS5233 : update : 2025/03/24 |
|||
| Comment | Currently not ready. Disease specific iPS cell line derived from a patient : Ullrich congenital muscular dystrophy. HPS3863, HPS3864, HPS5233 were derived from the same patient. | ||
| Comment from the depositor | Disease-specific iPS cell line (Ullrich congenital muscular dystrophy) : Established by the transduction of 7 factors (hL-MYC, hLIN28, hSOX2, hKLF4, OCT3/4, mp53DD, EBNA1) with episomal vector system into fibroblast cells from a Ullrich congenital muscular dystrophy patient. | ||
| Terms and conditions | 1) In relation to the for-profit organizations, please contact iPS Academia Japan, Inc., prior to the utilization of iPS cells. 2) Attach Appendix (non-for-profit) or Appendix (for-profit) to MTA (C-0007 or C-0007p) . 3) The RECIPIENT agrees to obtain the prior written approval of the distribution from the APPROVER. 4) Use of the material requires approval by institutional review board for research ethics. 5) Contact Us : RIKEN Cell Bank | ||
| Remarks | |||
| Order Form | Order Form(C-0042.pdf) Approval Form(C-0057.pdf) MTA(C-0007.pdf) MTA(C-0007p.pdf) | ||
| Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | |||
| Reference information | Reference | 1 | |
| User's Publication | 0 | ||
Top
Top
| User's Publication |
Back
CELL BANK Website